Corewell Health East
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Corewell Health East sits in the top decile of US sponsors by registered trial count (#231 of 15,742 sponsors by registered trial count).
Corewell Health East: 106 sponsored US clinical trials, 10 recruiting.
Corewell Health East sponsors 106 registered US clinical trials on ClinicalTrials.gov, 10 of them currently recruiting, and 61 completed. 12 of these trials are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Interstitial Cystitis, with 4 trials.
Top-decile sponsor footprint
Corewell Health East ranks in the top decile of sponsors by registered trial count (#231 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
61 of 94 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (64.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
106 total, page 1 of 3
Cardiac Radioablation for VT
NCT06593418
Magnesium and Cramping
NCT06745388
Sacral Neuromodulation for Chronic Pelvic Pain
NCT06150599
Effect of Peri-Urethral Stimulation on Intra-Urethral Pressure
NCT05900570
Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival
NCT06107361
Emsella Chair vs Sham for Male Sexual Dysfunction
NCT05370651
BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder
NCT04873037
BTL Emsella Chair Versus Sham for the Treatment of Stress Urinary Incontinence
NCT04133675
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
NCT02870738
Quantitative MRI Assessment of Breast Cancer Therapy Response
NCT05704062
Anterior Cervical Disectomy And Fusion Using The Tritanium® C Anterior Cervical Cage For One Or Two-Levels
NCT04214535
Hypofractionated Regional Nodal Irradiation in Breast Cancer
NCT06443359
Improving Vaccine Counseling Skills Among Residents Using Educational Modules and Standardized Patient Encounters
NCT06074237
Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty
NCT05297305
Evaluation of a New Bladder Health Mobile Application in Pregnancy
NCT04074044
Pediatric Obesity Management Study
NCT05622981
PTNS for Female Patients Suffering From Multiple Sclerosis
NCT05422625
Treatment of Pneumocystis in COPD (the TOPIC Study)
NCT05418777
Acute Pudendal Nerve Stimulation On Leak Point Pressure In Women Urodynamic Early Feasibility Study
NCT05128682
Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases
NCT04119115
Blood Sampling Functionality of Extended Dwell Catheters
NCT04409418
The Impact of Vaccination on Severity of Illness in COVID-19
NCT04912700
Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis
NCT04175392
Utility of Continuous Pulse Oximetry for Pediatric Patients With Stable Respiratory Illness
NCT04407806
Nasal Suction in Infants With Bronchiolitis Using a NoseFrida vs. Bulb Syringe
NCT04599101
Reduce Radiation Exposure in Fluoroscopic Interventions Evaluation
NCT04404257
ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)
NCT04432272
Emsella Chair Versus Sham for the Treatment of Chronic Pelvic Pain
NCT04248491
Does Topical Ophthalmic Anesthetic Prior to Probing and Irrigation Decrease Pain?
NCT04229771
Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2
NCT04320511
Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19
NCT04365985
Beaumont Health Large-scale Automated Serologic Testing for COVID-19
NCT04349202
Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units
NCT04829552
Postoperative Activity Restrictions in Children
NCT04145895
Postoperative Pain Control in Septum and Sinus Surgery
NCT04149964
Study of Low Dose Whole Brain Irradiation in the Treatment of Alzheimer's Disease
NCT02359864
Peripheral Intravenous Catheter Securement With Tissue Adhesive
NCT04086693
Clinical Outcomes Associated With the Use of ViviGen® for the Treatment of Lumbar Degenerative Disc Disease
NCT03733626
Midlines and Thrombophlebitis
NCT03725293
Prospective Study of Fusion Rates Using Spira-C Device for Anterior Cervical Discectomy and Fusion Surgery
NCT03786432
Ultrasound Guided Catheter Length Survivability
NCT03655106
Laser Therapy for Treatment of Urogenital Symptoms in Women
NCT03681678
IN Ketamine vs IN Midazolam and Fentanyl for Laceration Repair
NCT03528512
OnabotulinumtoxinA Bladder Injection Study
NCT03523091
Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal
NCT03447639
Sham Controlled Trial of Rapid Induction Percutaneous Tibial Nerve Stimulation
NCT03547518
Impact of Pharmacy Clinic on Diabetes Management
NCT03377127
The Kickstart Health Program
NCT03308162
Comprehensive Care Program SBRT
NCT03267368
The Computed Tomography-derived Fractional Flow Reserve STAT Trial
NCT03263806
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 8 |
| Phase 3 | 4 |
| Phase 4 | 8 |
What is open in the Corewell Health East pipeline
10 recruiting of 106 indexed (9% open); 61 completed (58%).
Phase mix: 12 late (III/IV) vs 11 early (I/II) (balanced across stages).
Top condition: Interstitial Cystitis (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Corewell Health East: open-pipeline peers nationwide
Peers matched on 106 registered trials and 9% open enrollment, not the therapeutic-area sidebar.
Corewell Health East sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 106 trials (± recruiting share)
- Augusta University · 106 trials · 12% recruiting
- University of Delaware · 106 trials · 23% recruiting
- Geisinger Clinic · 107 trials · 9% recruiting
- St. Louis University · 107 trials · 11% recruiting
Sponsors near 9% open enrollment (± trial volume)
- Apellis Pharmaceuticals · 10% recruiting · 21 trials
- Hologic · 10% recruiting · 21 trials
- Southern Illinois University · 10% recruiting · 21 trials
- Lahey Clinic · 9% recruiting · 43 trials
Related
What to do with this Corewell Health East page
106 registered trials is a research-attention snapshot, not an endorsement of Corewell Health East or any single study.
- 10 of Corewell Health East's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Interstitial Cystitis is the condition Corewell Health East studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Interstitial Cystitis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Corewell Health East pipeline card: 106 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.